相似文献
1
Comparison of cost-effectiveness of long-acting depot injection antipsychotics and oral antipsychotics in patients with schizophrenia in a rural community in South India.长效注射用抗精神病药物与口服抗精神病药物治疗印度南部农村社区精神分裂症患者的成本效益比较。
Indian J Psychiatry. 2020 Nov-Dec;62(6):747-748. doi: 10.4103/psychiatry.IndianJPsychiatry_670_19. Epub 2020 Dec 12.
2
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析：长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
3
The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations.长效/缓释抗精神病药治疗精神分裂症的成本效益：经济评价的系统评价。
Appl Health Econ Health Policy. 2013 Apr;11(2):95-106. doi: 10.1007/s40258-013-0016-2.
4
Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.长效注射用利培酮治疗精神分裂症：临床视角
Drugs. 2007;67(11):1541-66. doi: 10.2165/00003495-200767110-00003.
5
Comparing the efficacy of long-acting pharmaceutical forms (depot) versus oral pharmaceutical forms of atypical and conventional antipsychotics used in Spain for treating patients with schizophrenia.比较长效药物（长效针剂）与西班牙用于治疗精神分裂症患者的典型和传统抗精神病药物的口服药物剂型的疗效。
Rev Psiquiatr Salud Ment. 2009 Mar;2(1):5-28. doi: 10.1016/S1888-9891(09)70710-4. Epub 2009 May 6.
6
Depot antipsychotics: Where do we stand?长效抗精神病药物：我们目前的状况如何？
Ann Clin Psychiatry. 2016 Nov;28(4):289-298.
7
Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs.台湾地区精神分裂症的药物经济学评估：基于估算成本的长效利培酮、奥氮平与长效氟哌啶醇的模型比较
Psychiatry Clin Neurosci. 2005 Aug;59(4):385-94. doi: 10.1111/j.1440-1819.2005.01390.x.
8
Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.长效与口服抗精神病药治疗精神分裂症的疗效和效果：综合不同研究设计的结果。
J Clin Psychiatry. 2013 Jun;74(6):568-75. doi: 10.4088/JCP.12r08167. Epub 2013 Apr 19.
9
Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.长效利培酮注射剂与其他抗精神病药物在美国精神分裂症患者中的成本效益比较。
Pharmacoeconomics. 2005;23 Suppl 1:75-89. doi: 10.2165/00019053-200523001-00007.
10
Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone.先前使用传统长效抗精神病药物病情稳定的精神分裂症患者，在接受长效利培酮治疗后临床症状有显著改善。
Eur Psychiatry. 2004 Jun;19(4):219-25. doi: 10.1016/j.eurpsy.2003.11.007.
引用本文的文献
1
Use of Long-Acting Injectable Antipsychotics in a Clinical Sample of Community-Dwelling Patients with Schizophrenia-Spectrum Disorders in Rural Greece.长效注射用抗精神病药物在希腊农村社区精神分裂症谱系障碍患者临床样本中的应用。
J Clin Med. 2023 Mar 26;12(7):2508. doi: 10.3390/jcm12072508.
2
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries.呼吁在中低收入国家采取政策行动，增加长效抗精神病药物的可及性。
Epidemiol Psychiatr Sci. 2022 May 11;31:e34. doi: 10.1017/S2045796022000166.
本文引用的文献
1
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.精神分裂症患者对抗精神病药物的依从性：挑战与管理策略
Patient Relat Outcome Meas. 2014 Jun 23;5:43-62. doi: 10.2147/PROM.S42735. eCollection 2014.
2
Research on antipsychotics in India.印度的抗精神病药物研究。
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S317-40. doi: 10.4103/0019-5545.69261.
3
Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia.精神分裂症门诊治疗中抗精神病药物治疗不依从的预测因素和临床后果。
Psychiatry Res. 2010 Apr 30;176(2-3):109-13. doi: 10.1016/j.psychres.2009.05.004. Epub 2010 Feb 24.
4
Cognitive deficits and functional outcome in schizophrenia.精神分裂症的认知缺陷和功能结果。
Neuropsychiatr Dis Treat. 2006 Dec;2(4):531-6. doi: 10.2147/nedt.2006.2.4.531.
5
Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.精神分裂症的精神症状与生活质量：一项荟萃分析。
Schizophr Bull. 2007 Sep;33(5):1225-37. doi: 10.1093/schbul/sbl071. Epub 2007 Jan 4.
6
Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis.长效利培酮与口服奥氮平和氟哌啶醇长效注射剂治疗精神分裂症的比利时成本效益分析
Pharmacoeconomics. 2005;23 Suppl 1:35-47. doi: 10.2165/00019053-200523001-00004.
7
Predictors of noncompliance in patients with schizophrenia.精神分裂症患者不依从性的预测因素
J Clin Psychiatry. 2002 Dec;63(12):1121-8. doi: 10.4088/jcp.v63n1206.
8
Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.精神分裂症患者的依从性评估及长效抗精神病药物的使用
J Clin Psychiatry. 2001 Jul;62(7):545-51. doi: 10.4088/jcp.v62n07a08.
9
Depot neuroleptic therapy: an underutilized treatment option.长效抗精神病药物治疗：一种未得到充分利用的治疗选择。
J Clin Psychiatry. 1992 Dec;53(12):426-33.
Zotero 插件